for Sep 14, 2021
Anyone who does inpatient ID and tries to set up home IV antibiotic therapy will instantly recognize why daptomycin is far superior to vanco for patient satisfaction -- ESPECIALLY with vanco q8 hours. That's some kind of torturehttps://t.co/FL614DBxpk @mmPharmD pic.twitter.com/OlhuctDHgd
— Paul Sax (@PaulSaxMD) September 14, 2021
Dr. Anthony Fauci, the director of the National Institute for Allergies and Infectious Diseases and a White House medical adviser, says that he supports mandating vaccinations for airline passengers. https://t.co/Rf9vkTS68a pic.twitter.com/vdjtjrKJ43
— FOX 13 News Utah (@fox13) September 14, 2021
Unvaccinated Covid-19 patients cost $5.7 billion for treatment in the last 3 months, study estimates. Study by @KFF Cost of treating COVID-19 hospitalizations among unvaccinated was $0.6B in June; $1.4B in July & $3.7B in Sept. https://t.co/jq2ChrGPf8
— Carlos del Rio (@CarlosdelRio7) September 14, 2021
⛔Are you aware of this important interaction?, not in lexicomp⛔
— Antibiotic Steward 🆔🇵🇸 Bassam Ghanem (@ABsteward) September 14, 2021
Broad-spectrum azoles and flucloxacillin: a dangerous match
Flucloxacillin ⬇️ the level of voriconazole or Isavuconazole, we need TDM #IDTwitter #medtwitter #TwitteRx https://t.co/ElbmRvWQFm
Resistance to copper, which is mobilized to the urine as a host response during urinary tract infections, is a fitness factor for MRSA during infection. @mBioJournal https://t.co/noCp3mcaeU pic.twitter.com/crSPeKSJPJ
— ASM (@ASMicrobiology) September 14, 2021
Lets talk fungi 🍄
— BSAC (@BSACandJAC) September 14, 2021
Improve your understanding of how fungi cause disease and effective treatments for fungal infection with our #CPD accredited course. You will explore #AntifungalStewardship with a community of over 3400 learners. #AntifungalAMS https://t.co/LmuVGIRaww pic.twitter.com/ydogwgWfT3
A new systematic review in OFID finds that fatigue after COVID-19 is common but generally resolves over months and may result from end-organ injury or mental health conditions.
— IDSA (@IDSAInfo) September 14, 2021
📄:https://t.co/yORltbfFE6 #IDSAJournals @PaulSaxMD @DrJLi @jobadd @SandlerCarolina pic.twitter.com/tjI3n81eEe
Learning a lot more about DOOR for infectious diseases outcomes, specifically rapid diagnostics by our very own member @ClaeysKcclaeys #rxtwitter #idtwitterhttps://t.co/FE3ZjMcmgD pic.twitter.com/eOk0rz0WKQ
— ACCP INFD PRN (@accpinfdprn) September 14, 2021
Johnson & Johnson said its Ebola vaccine regimen demonstrated antibody immune responses in adults and children, citing data published in the Lancet Infectious Diseases journal. https://t.co/HSjY1Dh61F
— ABS-CBN News (@ABSCBNNews) September 14, 2021
“#Antimicrobial resistance threatens to rob us of the #antibiotics we rely upon for the treatment of infectious diseases -- and of many of our modern medical advances,” @PreventionChick warns. https://t.co/rSz0qLrePQ
— Save Antibiotics (@saveantibiotics) September 14, 2021
Recreational boating has a relatively small, but significant, effect on meiofauna alpha diversity and meiofauna and bacterial community composition. @mSphereJ https://t.co/dnHCeuGSTR pic.twitter.com/FD06q5HJqf
— ASM (@ASMicrobiology) September 14, 2021
Join us today for the inaugural @EmoryDeptofMed Grand Rounds for the 2021-22 academic year. The topic will be "COVID-19: The Delta Variant and Vaccinations" with @angie_rasmussen & @SaadOmer3 as invited speakers. To receive a Zoom link register at: https://t.co/ghUOxTnNXT pic.twitter.com/YJN9m8kz4m
— Carlos del Rio (@CarlosdelRio7) September 14, 2021
Excellent review @NatRevImmunol
— Antibiotic Steward 🆔🇵🇸 Bassam Ghanem (@ABsteward) September 14, 2021
Immune-mediated inflammatory disease(IMIDs) therapeutics: past, present and future
✨Fantastic timeline of therapeutic strategies for (IMIDs) from methotrexate to JAK inhibitors✨ #medtwitter #TwitteRx https://t.co/v5GHZRjAKf pic.twitter.com/RoHzbYRZTk
2 #Ebola vaccine trials
— The Lancet Infectious Diseases (@TheLancetInfDis) September 14, 2021
1) Safety and long-term immunogenicity of the two-dose heterologous Ad26.ZEBOV and MVA-BN-Filo Ebola vaccine regimen in adults in Sierra Leone https://t.co/Dk4By64ZhU
Johnson & Johnson said on Monday its Ebola vaccine regimen demonstrated antibody immune responses in adults and children, citing data published in the Lancet Infectious Diseases journal.https://t.co/DUJ1ENdBIt
— News24 (@News24) September 14, 2021
WOW! U.S. and Chinese researchers funded by the National Institutes of Allergy and Infectious Diseases created viruses in a Wuhan lab that exhibited over 10,000 times higher viral load in humanized mice, records released by the agency show. https://t.co/pDv6hx5YPm
— Joe McKinley (@bartmckinley) September 14, 2021
Johnson & Johnson said its Ebola vaccine regimen demonstrated antibody immune responses in adults and children, citing data published in the Lancet Infectious Diseases journal. https://t.co/Q8TPbqugUm pic.twitter.com/FfEoaI0Mbp
— Reuters Africa (@ReutersAfrica) September 14, 2021
"Alberta hospitals really are on the brink of collapse," said Dr. Ilan Schwartz, a physician and assistant professor in the division of infectious diseases at the University of Alberta.
— Kathleen Petty (@kathleen_petty) September 14, 2021
https://t.co/aISBm7ppXr
Johnson & Johnson said on Monday its Ebola vaccine regimen demonstrated antibody immune responses in adults and children, citing data published in the Lancet Infectious Diseases journal.https://t.co/h47D1bsGIG
— GMA News (@gmanews) September 14, 2021
🌟HAPPENING NOW | WEBINAR | Rapid Diagnostics & Biomarkers at the Heart of Patient Management Free Webinar 🌟
— ISAC (@ischemo) September 14, 2021
Hear our final speaker Prof. Heiman Wertheim presenton “Rapid biomarkers in the community to improve antibiotic use”https://t.co/6rWWjTZ1SY#antimicrobialstewardship pic.twitter.com/qqSc0ZKoCX
Johnson & Johnson said its Ebola vaccine regimen demonstrated antibody immune responses in adults and children, citing data published in the Lancet Infectious Diseases journal. https://t.co/Zzn2nkcrOW
— ABS-CBN News Channel (@ANCALERTS) September 14, 2021
ICYMI - there's still time to register for this #livewebinar discussing the #value of a laboratory/stewardship partnership 🤝🤝🤝
— SIDP (@SIDPharm) September 14, 2021
And registration is FREE for @SIDPharm and @accpinfdprn members - so check your email for the code!
Register here: https://t.co/MZOKlyDCsu pic.twitter.com/V5dliTX95P
Johnson & Johnson said on Monday its Ebola vaccine regimen demonstrated antibody immune responses in adults and children, citing data published in the Lancet Infectious Diseases journal. https://t.co/pIuPXF1xNr
— Reuters Health (@Reuters_Health) September 14, 2021
Did you know that febrile infectious childhood diseases (FICDs) are associated with a lower cancer risk in adulthood? https://t.co/n5WU9gIYer
— Physicians for Informed Consent (@picphysicians) September 14, 2021
Want to stay informed? https://t.co/tieJwPrrmZ#Physicians4InformedConsent #1stDoNoHarm #firstdonoharm #InformedConsent pic.twitter.com/k9NqxlNj3E
This is a good covid explainer.
— KD (@Fly_Sistah) September 14, 2021
Dr. Lisa Fitzpatrick On COVID Vaccine Side Effects & The 'New' Technology Of mRNA Vaccines https://t.co/4yV53fQa7I
Dr. Lisa Fitzpatrick, MD, MPH is a CDC-trained medical epidemiologist and board-certified infectious diseases physician.
In @ASMicrobiology combination therapy is related to a decrease in 30-day mortality in CRE patients, but only with antimicrobial regimens not containing CAZ-AVIhttps://t.co/KXMgkL9RtR pic.twitter.com/vuMtOfaGhy
— ACCP INFD PRN (@accpinfdprn) September 14, 2021
“Dear humans: face masks don’t work; the study-review was published by your very own CDC” – By Jon Rappoport
— Common Law 1215 (@1215_law) September 14, 2021
Published in: “Emerging Infectious https://t.co/luxtKCKg5T, No. 5, May 2020.” (That journal is published by the CDC.) pic.twitter.com/bOljrsTliG
Preparedness against #infectiousdiseases is an urgent necessity which it is now being taken more seriously by governments globally. The US Government is planning to invest $65bn into pandemic preparedness #vaccines #antivirals
— Poolbeg Pharma (@PoolbegPharma) September 14, 2021
Read the full report here: https://t.co/af1YKCKjaa
New in CID: The use of organs from donors with #HIV in recipients with HIV is increasing in the U.S., yet resistance that would compromise integrase strand transfer inhibitor-based regimens is rare, which is reassuring regarding safety.
— IDSA (@IDSAInfo) September 14, 2021
📄 https://t.co/9nQ1URpalx#IDSAJournals pic.twitter.com/NUUDpz7OTH
Vacancy: AMR Translational Research Lead, to support the National Pharmacy & Prescribing Clinical Lead for NHS E on Antimicrobial Prescribing Optimisation workstream. https://t.co/3TkZayTZ62 cc @DrKieranHand CLOSES tomorrow: 15.09.21 pic.twitter.com/pktf9PF0rB
— Diane Ashiru, PhD (@DrDianeAshiru) September 14, 2021
Congratulations, Algoma! 85% of residents 12 and older have received one dose of a COVID-19 vaccine! Thank you to everyone who's helped us reach this amazing milestone! Visit https://t.co/ntEzbugn3A to learn about future clinics happening near you. pic.twitter.com/9pf2Xk8QX9
— Algoma Public Health (@AlgomaHealth) September 14, 2021
“The #PASTEURAct is our opportunity to keep #antimicrobial resistance from becoming the next public health crisis. Without it, we may be facing devastating infections without any tools to fight back,” @JohnLynchID writes. https://t.co/JvqcSyxdhP
— Save Antibiotics (@saveantibiotics) September 14, 2021
2) Safety and immunogenicity of the two-dose heterologous Ad26.ZEBOV and MVA-BN-Filo Ebola vaccine regimen in children in Sierra Leone https://t.co/gALT2lumvG 🇸🇱
— The Lancet Infectious Diseases (@TheLancetInfDis) September 14, 2021
With schools reopening, crowds gathering and variants spreading, demand for COVID-19 testing is growing. Infectious diseases expert Dr. @diegohijano on what you need to know about coronavirus testing now. https://t.co/OWJDN1bKkU @lisaespo @usnews pic.twitter.com/uYxrBA62Ss
— St. Jude Research (@StJudeResearch) September 14, 2021
#Autophagy in major human diseases
— Hao Yin (@HaoYin20) September 14, 2021
"cancer as well as cardiovascular, neurodegenerative, metabolic, pulmonary, renal, infectious, musculoskeletal, and ocular disorders"
Do not miss this😎
Dr. Lorenzo Galluzzi & Federico Pietrocola labs @embojournal 2021https://t.co/WDIahqvMjE pic.twitter.com/hQ8tppIPVE
Rhizobacteria mediated seed bio-priming triggers the resistance and plant growth for sustainable crop productionhttps://t.co/Qh9xcfDm5d #openaccess pic.twitter.com/PauHLetTFY
— MicrobesInfect (@MicrobesInfect) September 14, 2021
The #COVID19 epidemic and other notifiable infectious diseases in Chinahttps://t.co/6LsvBcGGdl pic.twitter.com/IeTFLWy8RB
— MicrobesInfect (@MicrobesInfect) September 14, 2021
Today’s $472 million funding announcement includes more than $12 million for research on SARS-CoV-2 – the virus that causes COVID-19 – and over $84 million for research in infectious diseases. Read more in #NHMRC’s media release. 📢https://t.co/QE5yq0tzdn
— NHMRC (@nhmrc) September 14, 2021
#Autophagy dysfunction has been linked to human diseases ranging from #cancer to neurodegenerative, metabolic & infectious disorders.
— UMLifeSciences (@UMLifeSciences) September 14, 2021
In this @embojournal article, Dan Klionsky & coauthors review data regarding #authophagy's role in major human diseases: https://t.co/6ucCMyPzqH pic.twitter.com/n5NAv6Vm1R
Toronto NDP candidate doesn’t really apologize for antisemitic conspiratorial tweets that baselessly linked Israel to missing COVID-19 vaccines.
— Andrew Morris (@ASPphysician) September 14, 2021
I fixed the headline. https://t.co/VZ5YlYjIOi
📢HAPPENING TODAY | Free Webinar
— ISAC (@ischemo) September 14, 2021
Still time to register for today’s webinar on Rapid Diagnostics & Biomarkers at the Heart of Patient Management at 13.00 (UK) / 14.00 (CET).
Register now.https://t.co/pCVu2QiPGk #diagnostics #biomarkers #COVID19 #antimicrobialstewardship pic.twitter.com/b8hP0qYPoM
Singapore experience - local infectious diseases expert says 80% #covid19 vaccination is too low for Delta, at least 90% is needed, "which is technically not possible due to hardened anti-vaxxers or refusers." v @abcnews https://t.co/TbVh19DS3U
— Karen Barlow (@KJBar) September 14, 2021
In this @KorinMiller piece I’m quoted on how there’s no evidence that #COVID19 vaccines cause swollen testicles, contrary to celebrity testimony https://t.co/23DcHugTl5
— Amesh Adalja (@AmeshAA) September 14, 2021
SA's first study on long COVID is out. Here's what we know so far:@SECTION27news @CovidSupportSA @CovidCommsSA @CovidCoalition @nicd_sa @Tuliodna @krisp_news @saCOVID19mc
— Spotlight (@SpotlightNSP) September 14, 2021
Covid-19: Clearer picture of long #Covid slowly emerging https://t.co/pj9FPYS5MF via @health24_sa
Genome plasticity is an important characteristic for Scheffersomyces stipitis to adapt to hostile environments and is an essential factor for developing sustainable S. stipitis platforms for second-generation biofuel production. @mBioJournal https://t.co/PGG5p9dEiq pic.twitter.com/6d6i58tuyP
— ASM (@ASMicrobiology) September 14, 2021
Johnson & Johnson said on Monday its Ebola vaccine regimen demonstrated antibody immune responses in adults and children, citing data published in the Lancet Infectious Diseases journal. https://t.co/NFNP1PjsXa
— Reuters Health (@Reuters_Health) September 14, 2021
#Antimicrobial stewardship activities in public #healthcare facilities in #SouthAfrica : a baseline for future direction https://t.co/fB5fAnEPnL #OpenAccess #AntimicrobialResistance @SIPBS_Strath pic.twitter.com/bVNViNlnKj
— StrathclydeOA (@StrathclydeOA) September 14, 2021
Interesting: "This work suggests that contextual factors rather than evaluation over video may contribute to differences in antibiotic stewardship for direct-to-consumer telemedicine encounters." https://t.co/QIJyj5NBwH #AntibioticResistance
— Battle Superbugs (@battlesuperbugs) September 14, 2021
Plus linked Comment: #Ebola vaccines for mass immunisation in affected regions https://t.co/UDbIQhEhCz
— The Lancet Infectious Diseases (@TheLancetInfDis) September 14, 2021
83% of stem cell recipients produce antibodies after 2 #COVID19 vaccine doses
— CIDRAP (@CIDRAP) September 14, 2021
The study involved hematologic cancer patients (leukemia, etc), of whom 62% reached the highest possible antibody levelhttps://t.co/tSYcYUJPYC
Photo: Phil Roeder / Flickr cc pic.twitter.com/p0kgoIerTX
Increased Capsule Thickness and Hypermotility Are Traits of Carbapenem-Resistant Acinetobacter baumannii ST3 Strains Causing Fulminant Infection https://t.co/2EmFcym3om
— AntibioticResistance (@AntibioticResis) September 14, 2021
A JCU scientist plans to improve the detection and treatment of new infectious diseases by using a breakthrough technology in rural and remote health clinics that can stop outbreaks before they spread to the rest of Australia.https://t.co/MkGdpkgkzV pic.twitter.com/uKLPdrj2qh
— James Cook Uni (@jcu) September 14, 2021
Johnson & Johnson said on Monday its Ebola vaccine regimen demonstrated antibody immune responses in adults and children, citing data published in the Lancet Infectious Diseases journal.https://t.co/5zPcH3qJKi
— CGTN Africa (@cgtnafrica) September 14, 2021
Ensure that your kids are protected against 4 of the most common infectious diseases. With PRUMedCare - Select Infectious Diseases on Pulse, get cash assistance for Dengue, Malaria, Typhoid, or Measles. Available now on Pulse: https://t.co/2Ig5Z2n0uk
— Pru Life UK (@PruLifeUK) September 14, 2021
Terms & conditions apply pic.twitter.com/lflE1UPDqw
New Comment: India's #COVID19 vaccination drive: key challenges and resolutions https://t.co/lQHlD2WRiS by @India4World & colleagues
— The Lancet Infectious Diseases (@TheLancetInfDis) September 14, 2021
New review argues that whatever advantage #covid boosters provide would not outweigh the benefit of using those doses to protect the billions of people who remain unvaccinated worldwide.
— MicrobesInfect (@MicrobesInfect) September 14, 2021
Boosters may only be useful in some people with weak immune systemshttps://t.co/d6g9nl9J8Z
🆕 Study SARS-CoV-2-specific memory CD4+ T cells could be found at similar frequencies in the tonsils and peripheral blood in unexposed individuals, whereas functional SARS-CoV-2-specific memory CD8+ T cells were almost only detectable in the tonsils. https://t.co/1d6giU3UWn
— Antibiotic Steward 🆔🇵🇸 Bassam Ghanem (@ABsteward) September 14, 2021
NEWS SCAN: Antimicrobial resistance in aquatic animals #AMR #AntibioticStewardship; #CWD spread in Kansas; #Measles in Afghan refugeeshttps://t.co/zlYgYk1AzE
— CIDRAP (@CIDRAP) September 14, 2021
Our "Infection Control Matters" podcast has covered plenty of topics, with some amazing guests. A selection:
— Brett Mitchell (@1healthau) September 14, 2021
Air purifiers, COVID-19 myths, Compassion, pneumonia, Infusion set timing, Gaming, Languagehttps://t.co/HRjkjYPBqB @Claire_AVATAR @DidierPittet @julesstorr @claireekt
RubisCO and CO2 play essential roles in M. capsulatus Bath metabolism. Read more in @AppEnvMicro: https://t.co/0QNZ4RSIOV pic.twitter.com/dc4NhOLHOd
— ASM (@ASMicrobiology) September 14, 2021
Johnson & Johnson said on Monday its Ebola vaccine regimen demonstrated antibody immune responses in adults and children, citing data published in the Lancet Infectious Diseases journal.https://t.co/kDYlQjrP1u pic.twitter.com/BVR9yJiYt8
— SABC News (@SABCNews) September 14, 2021
Looking forward for 3 days of exciting science in the Avian Infectious Diseases 2021 meeting of the Microbiology Society 15-17 September https://t.co/WOdFjo26bO #Avian21
— Stathis Giotis (@stathisgiotis) September 14, 2021
This school year marks the first time many children are returning to the classroom. Dr. Audrey John, Chief of Infectious Diseases, spoke with @PhillyInquirer about the importance of getting your child’s flu shot early this year. https://t.co/t09meTn04e
— Children's Hospital (@ChildrensPhila) September 14, 2021
Interested in #clinmicro? Former #CPEP program director Peter Gilligan provides the inside scoop on CPEP fellowships, #ABMM certification and doors that they open: https://t.co/LEfqBhPffN #ASMClinMicro pic.twitter.com/A633u4Oy8D
— ASM (@ASMicrobiology) September 14, 2021
IDSA Immediate Past President Dr. @theIDFile and IDSA members Drs. Shanu Agarwal and Donald Dumford answer some questions from @beaconjournal about best practices for the vaccinated. Read more: https://t.co/Okq3YjuGG7
— IDSA (@IDSAInfo) September 14, 2021
https://t.co/beCUOJ6D5A
— ISAC (@ischemo) September 14, 2021
Hear from our experts on how rapid and novel diagnostics and technologies and their application can impact clinical practice and the provision of #microbiology, #infectiousdisease, #antimicrobialstewardship & #infectioncontrol services.
Bispecific antibodies represent a promising next-generation countermeasure against SARS-CoV-2 variants of concern
— Antibiotic Steward 🆔🇵🇸 Bassam Ghanem (@ABsteward) September 14, 2021
In this study two bispecific antibodies tested retained the ability to neutralize the Alpha, Beta, Gamma and Delta variants at near wild-type https://t.co/6bEZsNB5J3
Prevalence of MDR bacteria in an acute trauma hospital in Port-au-Prince, Haiti: a retrospective analysis from 2012 to 2018 https://t.co/aNa2U2pEly
— AntibioticResistance (@AntibioticResis) September 14, 2021
Women of Inspiration™ Podcast EP2 - Dr. Suzanne Donovan, Infectious Diseases Expert in Outbreak Management and Infection Prevention. Her inspiring story and facts from the frontlines #COVID19 Global Pandemic! LISTEN & RT → https://t.co/XXCn7Rie1d Spread the word, not the virus! pic.twitter.com/N8uHlPfEIr
— Universal Womens Network™️ (@UWomensNetwork) September 14, 2021
"Despite challenges with the Delta variant, the concept of #herdimmunity remains critically important,” @rfrancomd of @UAB_ID. @rfrancomd & @jabarocas discuss the Delta variant, school masking guidelines, and how herd immunity will be achieved. Listen: https://t.co/YvX6BrAUUS pic.twitter.com/6S9cBx9CRD
— IDSA (@IDSAInfo) September 14, 2021
Check out @nc_engel recent #TB publications in @cochranecollab and the International Journal of Infectious Diseases.
— SSHIFTB (@sshiftb) September 14, 2021
Link to the first article:https://t.co/In2NyQzuJF
Published in: “Emerging Infectious https://t.co/luxtKCKg5T, No. 5, May 2020.” (That journal is published by the CDC.)
— Common Law 1215 (@1215_law) September 14, 2021
“Dear humans: face masks don’t work; the study-review was published by your very own CDC” – By Jon Rappoport pic.twitter.com/IORujkzP4B
+Associated comments, rather soft take.
— Bertrand Delsuc (@BertrandBio) September 14, 2021
Remdesivir, on the road to DisCoVeRy - The Lancet Infectious Diseases https://t.co/Qd6svC5Bvn
Validation of a biomarker that is reliably predictive of vaccine efficacy, known as a ‘correlate of protection’ (CoP), may support approval of vaccines in lieu of large-scale efficacy studieshttps://t.co/Yj3K9DB6Ii pic.twitter.com/9Q06hpfRU5
— Antibiotic Steward 🆔🇵🇸 Bassam Ghanem (@ABsteward) September 14, 2021
Created by Cameron Forbes. Last updated September 20, 2021 at 05:16 EST.